Isoprostanes - A novel major group of oxidative stress markers.

2.50
Hdl Handle:
http://hdl.handle.net/10146/584063
Title:
Isoprostanes - A novel major group of oxidative stress markers.
Authors:
Czerska, Marta; Zielinski, Marek; Gromadzinska, Jolanta
Abstract:
Isoprostanes are a recently discovered group of prostaglandin isomers. Results of previous studies suggest that they can be used as oxidative stress markers, because in a number of cardiovascular, pulmonary and neurological diseases their levels in biological samples considerably increase. It has been found that people suffering from diabetes, obesity, homozygous familial hypercholesterolemia, moderate hypercholesterolemia, and smokers have higher levels of isoprostanes in urine. The same refers to patients with asthma, Alzheimer disease and Down syndrome. This paper reviews the results of relevant studies.
Affiliation:
Nofer Institute of Occupational Medicine, Lodz, Poland
Citation:
International Journal of Occupational Medicine and Environmental Health 2016;29(2):179 – 190
Journal:
International Journal of Occupational Medicine and Environmental Health
Issue Date:
17-Dec-2015
URI:
http://hdl.handle.net/10146/584063
DOI:
10.13075/ijomeh.1896.00596
PubMed ID:
26670350
Additional Links:
http://ijomeh.eu/Isoprostanes-A-novel-major-group-of-oxidative-stress-markers,58565,0,2.html
Type:
Article
Language:
en_US
ISSN:
1896-494X
Sponsors:
the statutory project IMP.1.32. “The concentration of F2 isoprostane in biological samples of the Lodz healthy population.”
Appears in Collections:
Articles

Full metadata record

DC FieldValue Language
dc.contributor.authorCzerska, Martaen
dc.contributor.authorZielinski, Mareken
dc.contributor.authorGromadzinska, Jolantaen
dc.date.accessioned2015-12-17T12:17:30Zen
dc.date.available2015-12-17T12:17:30Zen
dc.date.issued2015-12-17en
dc.identifier.citationInternational Journal of Occupational Medicine and Environmental Health 2016;29(2):179 – 190en
dc.identifier.issn1896-494Xen
dc.identifier.pmid26670350en
dc.identifier.doi10.13075/ijomeh.1896.00596en
dc.identifier.urihttp://hdl.handle.net/10146/584063en
dc.description.abstractIsoprostanes are a recently discovered group of prostaglandin isomers. Results of previous studies suggest that they can be used as oxidative stress markers, because in a number of cardiovascular, pulmonary and neurological diseases their levels in biological samples considerably increase. It has been found that people suffering from diabetes, obesity, homozygous familial hypercholesterolemia, moderate hypercholesterolemia, and smokers have higher levels of isoprostanes in urine. The same refers to patients with asthma, Alzheimer disease and Down syndrome. This paper reviews the results of relevant studies.en
dc.description.sponsorshipthe statutory project IMP.1.32. “The concentration of F2 isoprostane in biological samples of the Lodz healthy population.”en
dc.languageENGen
dc.language.isoen_USen
dc.relation.urlhttp://ijomeh.eu/Isoprostanes-A-novel-major-group-of-oxidative-stress-markers,58565,0,2.htmlen
dc.rightsArchived with thanks to International journal of occupational medicine and environmental healthen
dc.subjectIsoprostanesen
dc.subjectCardiovascularen
dc.subjectPulmonaryen
dc.subjectNeurologicalen
dc.subjectOxidative stress biomarkersen
dc.subjectAsbestosisen
dc.titleIsoprostanes - A novel major group of oxidative stress markers.en_US
dc.typeArticleen
dc.contributor.departmentNofer Institute of Occupational Medicine, Lodz, Polanden
dc.identifier.journalInternational Journal of Occupational Medicine and Environmental Healthen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in ECNIS-NIOM are protected by copyright, with all rights reserved, unless otherwise indicated.